ARMATA PHARMACEUTICALS, INC. — Key Metrics
2 years of history · ending 2020-12-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
Per Share Metrics
Working Capital Analysis
Valuation Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
Capital Deployment Yields
EPS (Diluted)
$-1
Book Value Per Share
$1
Free Cash Flow Per Share
$-1
Cash Per Share
$1
OCF Per Share
$-1
Return on Equity
-132.6%
Return on Assets
-68.3%
Return on Invested Capital
-102.0%
Current Ratio
1.62
Quick Ratio
1.62
Working Capital
$4M
Net Current Asset Value
$-10M
Invested Capital
$19M
OCF / Net Income
0.82
FCF / Net Income
0.86
Accruals Ratio (Sloan)
-9.9%
Net Debt
$-10M
Net Debt / EBITDA
0.47
Interest Coverage
-34.37
Cash Coverage
-29.09
Dividend Coverage
—
Capex Coverage
-22.17
Tangible Common Equity
$5M
TCE / Total Assets
12.9%
Goodwill / Total Assets
8.8%
NOPAT
$-17M
Cash ROIC
-114.2%
Capex / D&A
0.74
Reinvestment Rate
1.3%
Total Payout Ratio
—
Book Value 5Y CAGR
8.2%
Stock Price (FY-end)
$3
Market Cap
$49M
P/E Ratio
—
P/B Ratio
2.59
P/TB Ratio
9.57
Enterprise Value
$39M
FCF Yield
-39.0%
Dividend Yield
—
Shareholder Yield
-7.1%
R&D Yield
29.5%
Capex Yield
1.7%
Dividend Per Share
—
Graham Number
—
Shares Variation (YoY)
104.9%
Beta (5Y)
0.48
Cost of Equity
6.9%
52W High
$5
52W Low
$3
Trailing Return 1Y
-8.3%
Trailing Return 5Y
-99.4%
F-Score (Piotroski)
3.00
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.